Fanzhi Pharmaceutical is the one of the enterprises which specializes in production and trading of Glycyrrhiza extracts in China.we specialize in the R&D, production, and marketing of licorice derivatives. Main products: Monoammonium Glycyrrhizinate,18-beta-Glycyrrhetinic Acid,Stearyl Glycyrrhetinate, Dipotassium Glycyrrhizinate,Disodium Glycyrrhizinate and so on.
more >
Year of Establishment:
1995
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: